We have the unique ability and responsibility, because of our location in New York, to connect [pre-IPO biotech] companies with the financial markets and to work…
In Conversation
We are at the epicentre of cell and gene therapy, what we are calling ‘Cellicon Valley’. Nowhere else boasts such a concentration of cell and gene…
Recently, we have witnessed some profound policy developments that move us closer towards the holy grail of a learning healthcare system
This is both a hopeful and terrifying time to be a patient in the USA
My main focus is on accelerating clinical trials in rare disease by moving beyond “one disease at a time” approaches.
"We at ACRO have always focused on advocating for our members, as well as for our whole sector; our interest is an environment that is positive…
"Having enjoyed a highly positive start-up phase, we now need to put the right elements in place to ensure a successful phase two and continue delivering…
We are really starting to witness the advent of personalized therapies and smart missions in which there is a real convergence underway between diagnostic technologies and…
Across the board we are industry agnostic, meaning that whatever industry comes to us looking for support, we are happy to help
"We host the headquarters for the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the National Cancer Institute (NCI), among others."
"I believe having an excellent quality of life is critical to employee attraction and retention."
"‘FDA Beyond Our Borders’ is something that I remember with a great deal of pride and satisfaction, primarily because it was a major transformation for the…
